FXAIX
Price
$261.18
Change
-$2.08 (-0.79%)
Updated
Jul 13 closing price
Net Assets
827.51B
NYVRX
Price
$30.57
Change
+$0.13 (+0.43%)
Updated
Jul 10 closing price
Net Assets
7.56B
Interact to see
Advertisement

FXAIX vs NYVRX

FXAIX vs NYVRX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. NYVRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and NYVRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 828B vs. NYVRX (7.56B). FXAIX pays higher dividends than NYVRX: FXAIX (1.04) vs NYVRX (0.79). FXAIX was incepted earlier than NYVRX: FXAIX (15 years) vs NYVRX (23 years). NYVRX (1.20) is less costly to investors than FXAIX (0.01). NYVRX is a more actively managed with annual turnover of: 17.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than NYVRX: FXAIX (0) vs NYVRX (500000). FXAIX annual gain was more profitable for investors over the last year : 22.46 vs. NYVRX (15.42). FXAIX return over 5 years is better than : 85.95 vs. NYVRX (-6.62).
FXAIXNYVRXFXAIX / NYVRX
Total Expense Ratio0.011.201%
Annual Report Gross Expense Ratio0.011.201%
Fund Existence15 years23 years-
Gain YTD11.3505.889193%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets828B7.56B10,954%
Annual Yield % from dividends1.040.79132%
Returns for 1 year22.4615.42146%
Returns for 3 years74.9721.61347%
Returns for 5 years85.95-6.62-1,298%
Returns for 10 years288.2210.102,853%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMNIX16.11N/A
N/A
Vanguard Market Neutral I
ASQIX21.86N/A
N/A
American Century Small Company Inv
JOEIX17.73N/A
N/A
JOHCM Emerging Markets Opps Advisor
AEIYX9.29N/A
N/A
American Century Equity Income Y
EEMRX12.21N/A
N/A
MFS Emerging Markets Equity Research C